Related Experiment Video
Updated: May 11, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
FOLFIRINOX in locally advanced pancreas adenocarcinoma: back to the future?
Tanios Bekaii-Saab1, Richard M Goldberg
1Section of Gastrointestinal Oncology, Division of Medical Oncology, Department of Medicine, The Ohio State University/Arthur James Cancer Hospital and Richard Solove Research Institute, Columbus, Ohio 43210, USA. Tanios.Bekaii-Saab@osumc.rdu
The Oncologist
|May 25, 2013
Abstract
No abstract available in PubMed .
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...